Digoxin drug information | HelloPharmacist

Why is this medication prescribed?
How should this medicine be used?
Other uses for this medicine
What special precautions should I follow?
What special dietary instructions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?
What should I know about STORAGE and DISPOSAL of this medication?
What should I do in case of OVERDOSE?
What OTHER INFORMATION should I know?
Drug interactions

Why is this medication prescribed?

Digoxin is used to treat heart failure and abnormal heart rhythms (arrhythmias). It helps the heart work better and it helps control your heart rate.

How should this medicine be used?

Digoxin comes as a tablet, capsule, or pediatric elixir (liquid) to take by mouth. Digoxin is usually taken once a day. The pediatric elixir comes with a specially marked dropper for measuring the dose. If you have difficulty, ask your pharmacist to show you how to use it. It is important that you always take the same brand of digoxin. Different brands of digoxin have different amounts of active drug and your dose would need to be changed.

Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take digoxin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Digoxin helps control your condition but will not cure it. Continue to take digoxin even if you feel well. Do not stop taking digoxin without talking to your doctor.

Other uses for this medicine

Digoxin is also used to treat heart pain (angina) and may be used after a heart attack. Talk to your doctor about the possible risks of using this drug for your condition.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

What special precautions should I follow?

Before taking digoxin,

tell your doctor and pharmacist if you are allergic to digoxin, digitoxin, or any other drugs.

tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially antacids, antibiotics, calcium, corticosteroids, diuretics ('water pills'), other medications for heart disease, thyroid medications, and vitamins.

tell your doctor if you have or have ever had thyroid problems, heart arrhythmias, cancer, or kidney disease.

tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking digoxin, call your doctor.

talk to your doctor about the risks and benefits of taking this medication if you are 65 years of age or older. Older adults should usually receive low doses of digoxin because higher doses may cause serious side effects.

if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking digoxin.

you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

remember that alcohol can add to the drowsiness caused by this medication.

What special dietary instructions should I follow?

Your doctor may recommend a low-sodium (low-salt) diet and a potassium supplement. Ask your pharmacist or doctor for a list of foods that are low in sodium and high in potassium. Follow all diet directions carefully.

What should I do if I forget a dose?

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

What side effects can this medication cause?

Digoxin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- dizziness or lightheadedness
- drowsiness
- vision changes (blurred or yellow)
- rash
- irregular heartbeat

Some side effects may be serious. If you experience any of the following symptoms, call your doctor immediately:
- upset stomach
- vomiting
- diarrhea
- loss of appetite
- swelling of the feet or hands
- unusual weight gain
- difficulty breathing
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What should I know about STORAGE and DISPOSAL of this medication?

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

What should I do in case of OVERDOSE?

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

What OTHER INFORMATION should I know?

Keep all appointments with your doctor and the laboratory. Your doctor will need to determine your response to digoxin. You may have electrocardiograms (EKGs) and blood tests periodically, and your dose may need to be adjusted. Your doctor may ask you to check your pulse (heart rate). Ask your pharmacist or doctor to teach you how to take your pulse. If your pulse is faster or slower than it should be, call your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug interactions

Drug	Interaction
Moxifloxacin	Moxifloxacin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Moxifloxacin.
Repaglinide	Repaglinide Repaglinide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Atorvastatin	Atorvastatin The serum concentration of Digoxin can be increased when it is combined with Atorvastatin.
Dolasetron	Dolasetron The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dolasetron.
Anagrelide	Anagrelide The risk or severity of QTc prolongation can be increased when Digoxin is combined with Anagrelide.
Calcium Carbonate	Calcium Carbonate Calcium carbonate may increase the arrhythmogenic activities of Digoxin.
Candesartan	Candesartan The excretion of Digoxin can be decreased when combined with Candesartan.
Cilostazol	Cilostazol Cilostazol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diphenoxylate	Diphenoxylate The serum concentration of Digoxin can be increased when it is combined with Diphenoxylate.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The serum concentration of Digoxin can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fenofibrate	Fenofibrate Digoxin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine	Guanfacine Guanfacine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Magnesium Hydroxide	Magnesium Hydroxide Magnesium hydroxide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Magnesium Oxide	Magnesium Oxide The serum concentration of Digoxin can be decreased when it is combined with Magnesium oxide.
Miglitol	Miglitol The serum concentration of Digoxin can be decreased when it is combined with Miglitol.
Mycophenolate	Mycophenolate Mycophenolic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Olsalazine	Olsalazine Olsalazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Paregoric	Paregoric The serum concentration of Digoxin can be increased when it is combined with Morphine.
Penbutolol	Penbutolol Acebutolol may increase the arrhythmogenic activities of Digoxin.
Polyethylene glycol-electrolyte solution (PEG-ES)	Polyethylene glycol-electrolyte solution (PEG-ES) The serum concentration of Digoxin can be decreased when it is combined with Polyethylene glycol.
Potassium	Potassium Digoxin may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone	Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Digoxin.
Ranitidine	Ranitidine Digoxin may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine	Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Digoxin.
Rizatriptan	Rizatriptan Rizatriptan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sumatriptan	Sumatriptan Sumatriptan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tacrolimus	Tacrolimus Tacrolimus may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tizanidine	Tizanidine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Tizanidine.
Triamcinolone	Triamcinolone The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Digoxin.
Ampicillin Injection	Ampicillin Injection Ampicillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Famotidine Injection	Famotidine Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Famotidine.
Fluconazole Injection	Fluconazole Injection Fluconazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Foscarnet Injection	Foscarnet Injection Foscarnet may decrease the excretion rate of Digoxin which could result in a higher serum level.
Hydromorphone Injection	Hydromorphone Injection Hydromorphone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Levofloxacin Injection	Levofloxacin Injection Digoxin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection	Meperidine Injection Digoxin may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection	Methylprednisolone Injection The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Digoxin.
Metoclopramide Injection	Metoclopramide Injection The serum concentration of Digoxin can be decreased when it is combined with Metoclopramide.
Metronidazole Injection	Metronidazole Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Metronidazole.
Morphine Injection	Morphine Injection The serum concentration of Digoxin can be increased when it is combined with Morphine.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Vancomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Altretamine	Altretamine Amphetamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cyclosporine	Cyclosporine The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.
Ondansetron	Ondansetron The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ondansetron.
Enoxaparin Injection	Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Digoxin is combined with Enoxaparin.
Granisetron	Granisetron The risk or severity of QTc prolongation can be increased when Digoxin is combined with Granisetron.
Olanzapine	Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Digoxin.
Dofetilide	Dofetilide The risk or severity of torsade de pointes can be increased when Dofetilide is combined with Digoxin.
Eprosartan	Eprosartan The risk or severity of hyperkalemia can be increased when Digoxin is combined with Eprosartan.
Hydroxychloroquine	Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Hydroxychloroquine.
Pantoprazole	Pantoprazole Pantoprazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sevelamer	Sevelamer Sevelamer can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan	Telmisartan The serum concentration of Digoxin can be increased when it is combined with Telmisartan.
Temozolomide	Temozolomide Temozolomide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Zaleplon	Zaleplon Zaleplon may decrease the excretion rate of Digoxin which could result in a higher serum level.
Desloratadine	Desloratadine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Desloratadine.
Rivastigmine	Rivastigmine Digoxin may increase the bradycardic activities of Rivastigmine.
Trimipramine	Trimipramine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Trimipramine.
Glycopyrrolate	Glycopyrrolate The serum concentration of Digoxin can be increased when it is combined with Glycopyrronium.
Perindopril	Perindopril Perindopril may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tenofovir	Tenofovir Tenofovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sirolimus	Sirolimus The serum concentration of Digoxin can be increased when it is combined with Sirolimus.
Epinephrine Injection	Epinephrine Injection The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Digoxin.
Epirubicin	Epirubicin Epirubicin may decrease the cardiotoxic activities of Digoxin.
Eplerenone	Eplerenone Eplerenone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Escitalopram	Escitalopram The risk or severity of QTc prolongation can be increased when Digoxin is combined with Escitalopram.
Zonisamide	Zonisamide Zonisamide may increase the arrhythmogenic activities of Digoxin.
Aripiprazole	Aripiprazole The risk or severity of QTc prolongation can be increased when Digoxin is combined with Aripiprazole.
Atomoxetine	Atomoxetine Atomoxetine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ezetimibe	Ezetimibe Ezetimibe may decrease the excretion rate of Digoxin which could result in a higher serum level.
Teriparatide Injection	Teriparatide Injection The risk or severity of adverse effects can be increased when Teriparatide is combined with Digoxin.
Atazanavir	Atazanavir Atazanavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Almotriptan	Almotriptan Almotriptan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mefloquine	Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Digoxin.
Polyethylene Glycol 3350	Polyethylene Glycol 3350 The serum concentration of Digoxin can be decreased when it is combined with Polyethylene glycol.
Rosuvastatin	Rosuvastatin Rosuvastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vardenafil	Vardenafil Vardenafil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Alfuzosin	Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Digoxin.
Emtricitabine	Emtricitabine Digoxin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine	Memantine Memantine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tegaserod	Tegaserod The serum concentration of Digoxin can be increased when it is combined with Tegaserod.
Tadalafil	Tadalafil Tadalafil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Gemifloxacin	Gemifloxacin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Gemifloxacin.
Progesterone	Progesterone Progesterone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Apomorphine Injection	Apomorphine Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Apomorphine.
Protriptyline	Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Digoxin.
Duloxetine	Duloxetine Digoxin may decrease the excretion rate of Duloxetine which could result in a higher serum level.
Tinidazole	Tinidazole Tinidazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bosentan	Bosentan Bosentan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefditoren	Cefditoren Cefdinir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Erlotinib	Erlotinib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Erlotinib.
Eszopiclone	Eszopiclone Eszopiclone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ganciclovir	Ganciclovir Ganciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ribavirin	Ribavirin Ribavirin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Solifenacin	Solifenacin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Solifenacin.
Valganciclovir	Valganciclovir Valganciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Voriconazole	Voriconazole The risk or severity of QTc prolongation can be increased when Digoxin is combined with Voriconazole.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine Amphetamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Peginterferon Alfa-2a Injection	Peginterferon Alfa-2a Injection Digoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.
Exenatide Injection	Exenatide Injection The serum concentration of Digoxin can be decreased when it is combined with Exenatide.
Ibandronate	Ibandronate The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ibandronate.
Ramelteon	Ramelteon Ramelteon may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fentanyl	Fentanyl Digoxin may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin	Pregabalin Pregabalin may increase the arrhythmogenic activities of Digoxin.
Tipranavir	Tipranavir Tipranavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Felbamate	Felbamate The risk or severity of QTc prolongation can be increased when Digoxin is combined with Felbamate.
Rasagiline	Rasagiline Rasagiline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Imatinib	Imatinib Digoxin may decrease the excretion rate of Imatinib which could result in a higher serum level.
Sitagliptin	Sitagliptin Sitagliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Varenicline	Varenicline Varenicline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bevacizumab Injection	Bevacizumab Injection Digoxin may decrease the cardiotoxic activities of Bevacizumab.
Albuterol	Albuterol The serum concentration of Digoxin can be decreased when it is combined with Salbutamol.
Paliperidone	Paliperidone Paliperidone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bortezomib	Bortezomib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Bortezomib.
Clofarabine Injection	Clofarabine Injection Clofarabine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lubiprostone	Lubiprostone Lubiprostone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxaliplatin Injection	Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Oxaliplatin.
Posaconazole	Posaconazole The serum concentration of Digoxin can be increased when it is combined with Posaconazole.
Primaquine	Primaquine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Primaquine.
Aliskiren	Aliskiren The risk or severity of hyperkalemia can be increased when Digoxin is combined with Aliskiren.
Bismuth Subsalicylate	Bismuth Subsalicylate The serum concentration of Digoxin can be decreased when it is combined with Bismuth subsalicylate.
Darunavir	Darunavir The excretion of Digoxin can be decreased when combined with Darunavir.
Pemetrexed Injection	Pemetrexed Injection Digoxin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate	Dimenhydrinate The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dimenhydrinate.
Vorinostat	Vorinostat The risk or severity of QTc prolongation can be increased when Digoxin is combined with Vorinostat.
Sorafenib	Sorafenib Sorafenib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sunitinib	Sunitinib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Sunitinib.
Lapatinib	Lapatinib The bioavailability of Digoxin can be increased when combined with Lapatinib.
Levocetirizine	Levocetirizine Levocetirizine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pegaptanib Injection	Pegaptanib Injection Pegaptanib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dasatinib	Dasatinib The serum concentration of Digoxin can be increased when it is combined with Dasatinib.
Mexiletine	Mexiletine Mexiletine may increase the arrhythmogenic activities of Digoxin.
Azacitidine Injection	Azacitidine Injection Azacitidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ivermectin	Ivermectin The excretion of Digoxin can be decreased when combined with Ivermectin.
Temsirolimus	Temsirolimus The serum concentration of Digoxin can be increased when it is combined with Temsirolimus.
Lenalidomide	Lenalidomide Lenalidomide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nilotinib	Nilotinib Nilotinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Toremifene	Toremifene Toremifene may decrease the excretion rate of Digoxin which could result in a higher serum level.
Budesonide	Budesonide The risk or severity of adverse effects can be increased when Budesonide is combined with Digoxin.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Doripenem Injection	Doripenem Injection Doripenem may decrease the excretion rate of Digoxin which could result in a higher serum level.
Etravirine	Etravirine The serum concentration of Digoxin can be increased when it is combined with Etravirine.
Arsenic Trioxide Injection	Arsenic Trioxide Injection Digoxin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Mitoxantrone Injection	Mitoxantrone Injection Digoxin may decrease the cardiotoxic activities of Mitoxantrone.
Desvenlafaxine	Desvenlafaxine Desvenlafaxine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cevimeline	Cevimeline Cevimeline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nebivolol	Nebivolol Nebivolol may increase the arrhythmogenic activities of Digoxin.
Tretinoin	Tretinoin Digoxin may decrease the cardiotoxic activities of Tretinoin.
Bendamustine Injection	Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Digoxin.
Flecainide	Flecainide The serum concentration of Digoxin can be increased when it is combined with Flecainide.
Certolizumab Injection	Certolizumab Injection Certolizumab pegol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ixabepilone Injection	Ixabepilone Injection The serum concentration of Digoxin can be increased when it is combined with Ixabepilone.
Irinotecan Injection	Irinotecan Injection The excretion of Digoxin can be decreased when combined with Irinotecan.
Daptomycin Injection	Daptomycin Injection Daptomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methylnaltrexone Injection	Methylnaltrexone Injection Methylnaltrexone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Silodosin	Silodosin The serum concentration of Digoxin can be increased when it is combined with Silodosin.
Midazolam	Midazolam Midazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dexrazoxane Injection	Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Digoxin which could result in a higher serum level.
Eltrombopag	Eltrombopag The excretion of Digoxin can be decreased when combined with Eltrombopag.
Milnacipran	Milnacipran The risk or severity of hypotension can be increased when Milnacipran is combined with Digoxin.
Plerixafor Injection	Plerixafor Injection Plerixafor may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sodium Phosphate	Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Digoxin.
Fesoterodine	Fesoterodine Fesoterodine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Degarelix Injection	Degarelix Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Degarelix.
Betaxolol	Betaxolol Betaxolol may increase the arrhythmogenic activities of Digoxin.
Iloperidone	Iloperidone The risk or severity of QTc prolongation can be increased when Digoxin is combined with Iloperidone.
Prasugrel	Prasugrel Prasugrel may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lacosamide	Lacosamide Digoxin may increase the bradycardic activities of Lacosamide.
Everolimus	Everolimus The serum concentration of Digoxin can be increased when it is combined with Everolimus.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) The serum concentration of Digoxin can be increased when it is combined with Tolvaptan.
Dronedarone	Dronedarone Digoxin may increase the atrioventricular blocking (AV block) activities of Dronedarone.
Pralatrexate Injection	Pralatrexate Injection Pralatrexate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Palonosetron Injection	Palonosetron Injection Palonosetron may decrease the excretion rate of Digoxin which could result in a higher serum level.
Saxagliptin	Saxagliptin Saxagliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Telavancin Injection	Telavancin Injection Telavancin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Romidepsin Injection	Romidepsin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Romidepsin.
Topotecan	Topotecan Topotecan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pazopanib	Pazopanib The serum concentration of Digoxin can be increased when it is combined with Pazopanib.
Asenapine	Asenapine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Asenapine.
Pitavastatin	Pitavastatin Pitavastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dalfampridine	Dalfampridine Dalfampridine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fingolimod	Fingolimod Digoxin may increase the bradycardic activities of Fingolimod.
Eribulin Injection	Eribulin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Eribulin.
Cabazitaxel Injection	Cabazitaxel Injection The serum concentration of Digoxin can be increased when it is combined with Cabazitaxel.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lurasidone	Lurasidone The risk or severity of QTc prolongation can be increased when Digoxin is combined with Lurasidone.
Acetaminophen Injection	Acetaminophen Injection Acetaminophen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vilazodone	Vilazodone The serum concentration of Digoxin can be increased when it is combined with Vilazodone.
Ipilimumab Injection	Ipilimumab Injection Ipilimumab may decrease the excretion rate of Digoxin which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Terbutaline Injection	Terbutaline Injection Terbutaline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Azilsartan	Azilsartan The risk or severity of hyperkalemia can be increased when Digoxin is combined with Azilsartan medoxomil.
Busulfan Injection	Busulfan Injection Digoxin may decrease the cardiotoxic activities of Busulfan.
Roflumilast	Roflumilast Roflumilast may decrease the excretion rate of Digoxin which could result in a higher serum level.
Linagliptin	Linagliptin Linagliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rilpivirine	Rilpivirine The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Digoxin.
Telaprevir	Telaprevir Glecaprevir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Potassium Iodide	Potassium Iodide The serum concentration of Digoxin can be increased when it is combined with Potassium Iodide.
Cyclophosphamide Injection	Cyclophosphamide Injection Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.
Triptorelin Injection	Triptorelin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Triptorelin.
Rivaroxaban	Rivaroxaban Rivaroxaban may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ticagrelor	Ticagrelor The serum concentration of Digoxin can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection	Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Digoxin.
Ruxolitinib	Ruxolitinib Ruxolitinib may increase the bradycardic activities of Digoxin.
Vandetanib	Vandetanib Vandetanib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clobazam	Clobazam Clobazam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vemurafenib	Vemurafenib The serum concentration of Digoxin can be increased when it is combined with Vemurafenib.
Ivacaftor	Ivacaftor Ivacaftor may decrease the excretion rate of Digoxin which could result in a higher serum level.
Deferiprone	Deferiprone Deferiprone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Axitinib	Axitinib The serum concentration of Axitinib can be increased when it is combined with Digoxin.
Crizotinib	Crizotinib Crizotinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cabergoline	Cabergoline The serum concentration of Cabergoline can be increased when it is combined with Digoxin.
Naloxone Injection	Naloxone Injection Naloxone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ambrisentan	Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Digoxin.
Fondaparinux Injection	Fondaparinux Injection Fondaparinux may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pertuzumab Injection	Pertuzumab Injection Digoxin may decrease the cardiotoxic activities of Pertuzumab.
Carfilzomib Injection	Carfilzomib Injection Digoxin may decrease the excretion rate of Carfilzomib which could result in a higher serum level.
Enzalutamide	Enzalutamide Enzalutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mirabegron	Mirabegron Mirabegron may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bosutinib	Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Digoxin.
Corticotropin, Repository Injection	Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Corticotropin is combined with Digoxin.
Teriflunomide	Teriflunomide The excretion of Digoxin can be decreased when combined with Teriflunomide.
Teduglutide Injection	Teduglutide Injection Teduglutide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bedaquiline	Bedaquiline The risk or severity of QTc prolongation can be increased when Digoxin is combined with Bedaquiline.
Tofacitinib	Tofacitinib Digoxin may increase the bradycardic activities of Tofacitinib.
Alogliptin	Alogliptin Alogliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ponatinib	Ponatinib Ponatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pomalidomide	Pomalidomide Pomalidomide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The serum concentration of Digoxin can be increased when it is combined with Trastuzumab emtansine.
Apixaban	Apixaban The serum concentration of Digoxin can be increased when it is combined with Apixaban.
Canagliflozin	Canagliflozin The serum concentration of Digoxin can be increased when it is combined with Canagliflozin.
Methazolamide	Methazolamide Methazolamide may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib	Dabrafenib The serum concentration of Digoxin can be increased when it is combined with Dabrafenib.
Trametinib	Trametinib Trametinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dolutegravir	Dolutegravir The serum concentration of Digoxin can be increased when it is combined with Dolutegravir.
Afatinib	Afatinib Afatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Levomilnacipran	Levomilnacipran The risk or severity of hypotension can be increased when Levomilnacipran is combined with Digoxin.
Ertapenem Injection	Ertapenem Injection Ertapenem may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tigecycline Injection	Tigecycline Injection Tigecycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Vortioxetine	Vortioxetine Vortioxetine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lomitapide	Lomitapide Lomitapide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the excretion rate of Digoxin which could result in a higher serum level.
Simeprevir	Simeprevir Simeprevir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sofosbuvir	Sofosbuvir Sofosbuvir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dapagliflozin	Dapagliflozin Dapagliflozin may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast	Apremilast Apremilast may decrease the excretion rate of Digoxin which could result in a higher serum level.
Droxidopa	Droxidopa Droxidopa may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ceritinib	Ceritinib Digoxin may increase the bradycardic activities of Ceritinib.
Belinostat Injection	Belinostat Injection The serum concentration of Digoxin can be increased when it is combined with Belinostat.
Idelalisib	Idelalisib The serum concentration of Digoxin can be increased when it is combined with Idelalisib.
Testosterone Injection	Testosterone Injection Digoxin may decrease the excretion rate of Testosterone which could result in a higher serum level.
Vorapaxar	Vorapaxar Vorapaxar may decrease the excretion rate of Digoxin which could result in a higher serum level.
Suvorexant	Suvorexant Suvorexant may decrease the excretion rate of Digoxin which could result in a higher serum level.
Edoxaban	Edoxaban Edoxaban may decrease the excretion rate of Digoxin which could result in a higher serum level.
Caspofungin Injection	Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Digoxin.
Methamphetamine	Methamphetamine Metamfetamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tasimelteon	Tasimelteon Tasimelteon may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lanreotide Injection	Lanreotide Injection Digoxin may increase the bradycardic activities of Lanreotide.
Nintedanib	Nintedanib The serum concentration of Digoxin can be increased when it is combined with Nintedanib.
Risperidone Injection	Risperidone Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Risperidone.
Palbociclib	Palbociclib Palbociclib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lenvatinib	Lenvatinib Lenvatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Panobinostat	Panobinostat The serum concentration of Digoxin can be increased when it is combined with Panobinostat.
Haloperidol Injection	Haloperidol Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Haloperidol.
Deoxycholic Acid Injection	Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine	Ivabradine Ivabradine may increase the bradycardic activities of Digoxin.
Amiloride	Amiloride Amiloride may decrease the excretion rate of Digoxin which could result in a higher serum level.
Isavuconazonium Injection	Isavuconazonium Injection The serum concentration of Digoxin can be increased when it is combined with Isavuconazonium.
Macitentan	Macitentan Macitentan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Flibanserin	Flibanserin Flibanserin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rolapitant	Rolapitant Rolapitant may decrease the excretion rate of Digoxin which could result in a higher serum level.
Prednisolone	Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Digoxin.
Daclatasvir	Daclatasvir Daclatasvir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ziprasidone Injection	Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ziprasidone.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Procaine benzylpenicillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Eluxadoline	Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Digoxin.
Cobimetinib	Cobimetinib The serum concentration of Cobimetinib can be increased when it is combined with Digoxin.
Osimertinib	Osimertinib The serum concentration of Digoxin can be increased when it is combined with Osimertinib.
Ixazomib	Ixazomib Ixazomib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lesinurad	Lesinurad Lesinurad may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin.
Dexamethasone Injection	Dexamethasone Injection The risk or severity of adverse effects can be increased when Dexamethasone is combined with Digoxin.
Brivaracetam Injection	Brivaracetam Injection Brivaracetam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Venetoclax	Venetoclax Venetoclax may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cobicistat	Cobicistat Cobicistat may decrease the excretion rate of Digoxin which could result in a higher serum level.
Midodrine	Midodrine Digoxin may increase the bradycardic, atrioventricular blocking (AV block), and arrhythmogenic activities of Midodrine.
Selexipag	Selexipag The serum concentration of Selexipag can be increased when it is combined with Digoxin.
Diphenhydramine Injection	Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Diphenhydramine.
Calcifediol	Calcifediol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcifediol is combined with Digoxin.
Ergocalciferol	Ergocalciferol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Digoxin.
Doxercalciferol	Doxercalciferol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Doxercalciferol is combined with Digoxin.
Furosemide Injection	Furosemide Injection The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.
Rucaparib	Rucaparib Rucaparib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lixisenatide Injection	Lixisenatide Injection Lixisenatide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ribociclib	Ribociclib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ribociclib.
Parathyroid Hormone Injection	Parathyroid Hormone Injection The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Digoxin.
Doxepin (Insomnia)	Doxepin (Insomnia) Digoxin may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine	Deutetrabenazine Digoxin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine	Valbenazine Valbenazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Deflazacort	Deflazacort The risk or severity of adverse effects can be increased when Deflazacort is combined with Digoxin.
Naldemedine	Naldemedine Naldemedine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Neratinib	Neratinib Neratinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Enasidenib	Enasidenib Enasidenib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Inotuzumab Ozogamicin Injection	Inotuzumab Ozogamicin Injection The serum concentration of Digoxin can be increased when it is combined with Inotuzumab ozogamicin.
Benznidazole	Benznidazole Benznidazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Copanlisib Injection	Copanlisib Injection The serum concentration of Digoxin can be increased when it is combined with Copanlisib.
Delafloxacin	Delafloxacin Delafloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Abemaciclib	Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Digoxin.
Betrixaban	Betrixaban The serum concentration of Digoxin can be increased when it is combined with Betrixaban.
Letermovir	Letermovir Digoxin may decrease the excretion rate of Letermovir which could result in a higher serum level.
Tetrabenazine	Tetrabenazine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin The serum concentration of Digoxin can be increased when it is combined with Ertugliflozin.
Apalutamide	Apalutamide The serum concentration of Digoxin can be decreased when it is combined with Apalutamide.
Penicillamine	Penicillamine The serum concentration of Digoxin can be decreased when it is combined with Penicillamine.
Avatrombopag	Avatrombopag The serum concentration of Digoxin can be increased when it is combined with Avatrombopag.
Baricitinib	Baricitinib Baricitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lofexidine	Lofexidine Lofexidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Plazomicin Injection	Plazomicin Injection Plazomicin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Eliglustat	Eliglustat The serum concentration of Digoxin can be increased when it is combined with Eliglustat.
Encorafenib	Encorafenib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Encorafenib.
Binimetinib	Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Digoxin.
Ivosidenib	Ivosidenib Ivosidenib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lusutrombopag	Lusutrombopag The serum concentration of Digoxin can be increased when it is combined with Lusutrombopag.
Elagolix	Elagolix Digoxin may decrease the excretion rate of Elagolix which could result in a higher serum level.
Eravacycline Injection	Eravacycline Injection Eravacycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Tafenoquine	Tafenoquine The serum concentration of Digoxin can be increased when it is combined with Tafenoquine.
Dacomitinib	Dacomitinib Dacomitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Duvelisib	Duvelisib The serum concentration of Digoxin can be increased when it is combined with Duvelisib.
Omadacycline	Omadacycline Omadacycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Sarecycline	Sarecycline Sarecycline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Stiripentol	Stiripentol Stiripentol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Talazoparib	Talazoparib The serum concentration of Digoxin can be increased when it is combined with Talazoparib.
Gilteritinib	Gilteritinib The serum concentration of Digoxin can be increased when it is combined with Gilteritinib.
Glasdegib	Glasdegib Glasdegib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Larotrectinib	Larotrectinib The serum concentration of Digoxin can be increased when it is combined with Larotrectinib.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection Paclitaxel may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rifamycin	Rifamycin Rifamycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Prucalopride	Prucalopride Prucalopride may decrease the excretion rate of Digoxin which could result in a higher serum level.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Erdafitinib	Erdafitinib The serum concentration of Digoxin can be increased when it is combined with Erdafitinib.
Esomeprazole Injection	Esomeprazole Injection The serum concentration of Digoxin can be increased when it is combined with Esomeprazole.
Cladribine	Cladribine Digoxin may decrease the cardiotoxic activities of Cladribine.
Solriamfetol	Solriamfetol Solriamfetol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Darolutamide	Darolutamide The serum concentration of Digoxin can be increased when it is combined with Darolutamide.
Triclabendazole	Triclabendazole The risk or severity of QTc prolongation can be increased when Digoxin is combined with Triclabendazole.
Entrectinib	Entrectinib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Entrectinib.
Pexidartinib	Pexidartinib The excretion of Digoxin can be decreased when combined with Pexidartinib.
Istradefylline	Istradefylline The serum concentration of Digoxin can be increased when it is combined with Istradefylline.
Pitolisant	Pitolisant Pitolisant may increase the QTc-prolonging activities of Digoxin.
Fedratinib	Fedratinib Digoxin may decrease the excretion rate of Fedratinib which could result in a higher serum level.
Lefamulin	Lefamulin Digoxin may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection	Phenytoin Injection The serum concentration of Digoxin can be decreased when it is combined with Phenytoin.
Enfortumab vedotin-ejfv Injection	Enfortumab vedotin-ejfv Injection The serum concentration of Digoxin can be increased when it is combined with Enfortumab vedotin.
Lasmiditan	Lasmiditan The serum concentration of Digoxin can be increased when it is combined with Lasmiditan.
Ubrogepant	Ubrogepant The serum concentration of Digoxin can be increased when it is combined with Ubrogepant.
Calcium Acetate	Calcium Acetate Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Digoxin.
Tazemetostat	Tazemetostat The serum concentration of Digoxin can be increased when it is combined with Tazemetostat.
Bempedoic Acid	Bempedoic Acid The excretion of Digoxin can be decreased when combined with Bempedoic acid.
Selumetinib	Selumetinib The serum concentration of Digoxin can be increased when it is combined with Selumetinib.
Rimegepant	Rimegepant The serum concentration of Digoxin can be increased when it is combined with Rimegepant.
Tucatinib	Tucatinib Tucatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Remdesivir Injection	Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Digoxin.
Ripretinib	Ripretinib Ripretinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Capmatinib	Capmatinib The serum concentration of Digoxin can be increased when it is combined with Capmatinib.
Lemborexant	Lemborexant The serum concentration of Digoxin can be increased when it is combined with Lemborexant.
Fostemsavir	Fostemsavir The risk or severity of QTc prolongation can be increased when Digoxin is combined with Fostemsavir.
Octreotide	Octreotide The serum concentration of Digoxin can be decreased when it is combined with Octreotide.
Belantamab Mafodotin-blmf Injection	Belantamab Mafodotin-blmf Injection Digoxin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib	Pralsetinib Pralsetinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Relugolix	Relugolix The risk or severity of QTc prolongation can be increased when Digoxin is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives Digoxin may increase the excretion rate of Drospirenone which could result in a lower serum level and potentially a reduction in efficacy.
Vibegron	Vibegron The serum concentration of Digoxin can be increased when it is combined with Vibegron.
Viloxazine	Viloxazine Viloxazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fenoprofen	Fenoprofen Fenoprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Indomethacin	Indomethacin The serum concentration of Digoxin can be increased when it is combined with Indomethacin.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Naproxen	Naproxen Naproxen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolmetin	Tolmetin Tolmetin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sulindac	Sulindac Sulindac may decrease the excretion rate of Digoxin which could result in a higher serum level.
Trazodone	Trazodone The serum concentration of Digoxin can be increased when it is combined with Trazodone.
Isotretinoin	Isotretinoin Digoxin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate	Sucralfate Sucralfate can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Bicarbonate	Sodium Bicarbonate The serum concentration of Digoxin can be decreased when it is combined with Sodium bicarbonate.
Floxuridine	Floxuridine Floxuridine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Phenobarbital	Phenobarbital Phenobarbital may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Metaxalone	Metaxalone Metaxalone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methotrexate Injection	Methotrexate Injection Methotrexate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methsuximide	Methsuximide Methsuximide may increase the arrhythmogenic activities of Digoxin.
Chlorpromazine	Chlorpromazine Chlorpromazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diazepam	Diazepam Diazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxazepam	Oxazepam Oxazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Flurazepam	Flurazepam Digoxin may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate	Clorazepate Clorazepic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lorazepam	Lorazepam Lorazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Carmustine	Carmustine Carmustine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amantadine	Amantadine Amantadine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Codeine	Codeine Codeine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Phenelzine	Phenelzine Phenelzine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tetracycline	Tetracycline The serum concentration of Digoxin can be increased when it is combined with Tetracycline.
Minocycline	Minocycline Minocycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Demeclocycline	Demeclocycline Demeclocycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Prochlorperazine	Prochlorperazine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Prochlorperazine.
Thioridazine	Thioridazine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Thioridazine.
Bleomycin	Bleomycin Bleomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sulfadiazine	Sulfadiazine Sulfadiazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methadone	Methadone Methadone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Benztropine	Benztropine Benzatropine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Colestipol	Colestipol The serum concentration of Digoxin can be decreased when it is combined with Colestipol.
Maprotiline	Maprotiline Maprotiline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ibuprofen	Ibuprofen The serum concentration of Digoxin can be increased when it is combined with Ibuprofen.
Orphenadrine	Orphenadrine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Orphenadrine.
Azathioprine	Azathioprine Azathioprine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methylphenidate	Methylphenidate Methylphenidate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amoxapine	Amoxapine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Amoxapine.
Sulfasalazine	Sulfasalazine The serum concentration of Digoxin can be decreased when it is combined with Sulfasalazine.
Hydrocortisone	Hydrocortisone The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Digoxin.
Doxorubicin	Doxorubicin Digoxin may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Mechlorethamine	Mechlorethamine Digoxin may decrease the cardiotoxic activities of Mechlorethamine.
Dactinomycin	Dactinomycin The serum concentration of Digoxin can be increased when it is combined with Dactinomycin.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Carbamazepine	Carbamazepine Digoxin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa	Methyldopa Methyldopa may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clonidine	Clonidine Clonidine may increase the atrioventricular blocking (AV block) activities of Digoxin.
Hydralazine	Hydralazine Hydralazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cimetidine	Cimetidine Cimetidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Gentamicin Injection	Gentamicin Injection The serum concentration of Digoxin can be increased when it is combined with Gentamicin.
Warfarin	Warfarin Digoxin may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam	Clonazepam Clonazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loperamide	Loperamide Loperamide may increase the arrhythmogenic activities of Digoxin.
Promethazine	Promethazine Digoxin may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Daunorubicin	Daunorubicin Digoxin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nitrofurantoin	Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine	Loxapine Loxapine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine	Chloroquine Digoxin may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine	Quinine The serum concentration of Digoxin can be increased when it is combined with Quinine.
Ethosuximide	Ethosuximide Ethosuximide may increase the arrhythmogenic activities of Digoxin.
Calcitriol	Calcitriol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcitriol is combined with Digoxin.
Triamterene	Triamterene Triamterene may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sulfinpyrazone	Sulfinpyrazone Sulfinpyrazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chlorothiazide	Chlorothiazide Chlorothiazide may increase the hypokalemic activities of Digoxin.
Chlorthalidone	Chlorthalidone The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.
Metolazone	Metolazone Metolazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection	Clindamycin Injection The serum concentration of Digoxin can be increased when it is combined with Clindamycin.
Secobarbital	Secobarbital Secobarbital may decrease the excretion rate of Digoxin which could result in a higher serum level.
Desipramine	Desipramine Digoxin may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline	Amitriptyline Amitriptyline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Imipramine	Imipramine Digoxin may decrease the excretion rate of Imipramine which could result in a higher serum level.
Probenecid	Probenecid Probenecid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Quinidine	Quinidine The serum concentration of Digoxin can be increased when it is combined with Quinidine.
Procainamide	Procainamide Digoxin may increase the arrhythmogenic activities of Procainamide.
Isoniazid	Isoniazid Isoniazid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pyrazinamide	Pyrazinamide Pyrazinamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rifampin	Rifampin The serum concentration of Digoxin can be decreased when it is combined with Rifampicin.
Disopyramide	Disopyramide Digoxin may increase the arrhythmogenic activities of Disopyramide.
Valproic Acid	Valproic Acid The risk or severity of QTc prolongation can be increased when Digoxin is combined with Valproic acid.
Tamoxifen	Tamoxifen Tamoxifen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mitomycin	Mitomycin Digoxin may decrease the cardiotoxic activities of Mitomycin.
Butabarbital	Butabarbital Butabarbital may decrease the excretion rate of Digoxin which could result in a higher serum level.
Levothyroxine	Levothyroxine Levothyroxine may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Liothyronine	Liothyronine The serum concentration of Liothyronine can be decreased when it is combined with Digoxin.
Methimazole	Methimazole The serum concentration of Digoxin can be increased when it is combined with Methimazole.
Propylthiouracil	Propylthiouracil The serum concentration of Digoxin can be increased when it is combined with Propylthiouracil.
Chlorpropamide	Chlorpropamide Chlorpropamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolbutamide	Tolbutamide Tolbutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolazamide	Tolazamide Tolazamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dinoprostone	Dinoprostone The excretion of Dinoprostone can be decreased when combined with Digoxin.
Baclofen	Baclofen Baclofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Doxylamine	Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Digoxin.
Cyproheptadine	Cyproheptadine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Cyproheptadine.
Clemastine	Clemastine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Clemastine.
Chlorpheniramine	Chlorpheniramine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Chlorpheniramine.
Brompheniramine	Brompheniramine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dexbrompheniramine.
Ethambutol	Ethambutol Ethambutol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methyclothiazide	Methyclothiazide Methyclothiazide may increase the hypokalemic activities of Digoxin.
Hydrochlorothiazide	Hydrochlorothiazide Hydrochlorothiazide may increase the hypokalemic activities of Digoxin.
Dantrolene	Dantrolene The risk or severity of hyperkalemia can be increased when Digoxin is combined with Dantrolene.
Chlorzoxazone	Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Disulfiram	Disulfiram Disulfiram may decrease the excretion rate of Digoxin which could result in a higher serum level.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) Propranolol may increase the arrhythmogenic activities of Digoxin.
Nortriptyline	Nortriptyline The risk or severity of QTc prolongation can be increased when Digoxin is combined with Nortriptyline.
Spironolactone	Spironolactone The serum concentration of Digoxin can be increased when it is combined with Spironolactone.
Amphotericin B Injection	Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin.
Phytonadione	Phytonadione Phylloquinone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nadolol	Nadolol Nadolol may increase the arrhythmogenic activities of Digoxin.
Cholestyramine Resin	Cholestyramine Resin The serum concentration of Digoxin can be decreased when it is combined with Cholestyramine.
Allopurinol	Allopurinol Allopurinol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxytocin Injection	Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Digoxin.
Clomiphene	Clomiphene The serum concentration of Digoxin can be increased when it is combined with Clomifene.
Flavoxate	Flavoxate Flavoxate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Papaverine	Papaverine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Papaverine.
Fluorouracil Injection	Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Fluorouracil.
Colchicine	Colchicine Colchicine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cephalexin	Cephalexin Cephalexin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dacarbazine	Dacarbazine Dacarbazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Acetazolamide	Acetazolamide Acetazolamide may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Nystatin	Nystatin The excretion of Digoxin can be decreased when combined with Nystatin.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ketoconazole	Ketoconazole The serum concentration of Digoxin can be increased when it is combined with Ketoconazole.
Pyrantel	Pyrantel Pyrantel may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vincristine Injection	Vincristine Injection Vincristine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Captopril	Captopril The serum concentration of Digoxin can be increased when it is combined with Captopril.
Dipyridamole	Dipyridamole Dipyridamole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vinblastine	Vinblastine Vinblastine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ethacrynic Acid	Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Digoxin.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Metoprolol	Metoprolol Metoprolol may increase the arrhythmogenic activities of Digoxin.
Hydroxyzine	Hydroxyzine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Hydroxyzine.
Thiothixene	Thiothixene The risk or severity of QTc prolongation can be increased when Digoxin is combined with Thiothixene.
Aspirin	Aspirin Acetylsalicylic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Salsalate	Salsalate Salsalate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Alprazolam	Alprazolam The serum concentration of Digoxin can be increased when it is combined with Alprazolam.
Temazepam	Temazepam Temazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Triazolam	Triazolam Triazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dicyclomine	Dicyclomine Dicyclomine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Hyoscyamine	Hyoscyamine Digoxin may increase the arrhythmogenic activities of Hyoscyamine.
Propantheline	Propantheline The serum concentration of Digoxin can be increased when it is combined with Propantheline.
Trimethoprim	Trimethoprim The serum concentration of Digoxin can be increased when it is combined with Trimethoprim.
Diltiazem	Diltiazem The serum concentration of Digoxin can be increased when it is combined with Diltiazem.
Nifedipine	Nifedipine The serum concentration of Digoxin can be increased when it is combined with Nifedipine.
Timolol	Timolol Timolol may increase the arrhythmogenic activities of Digoxin.
Verapamil	Verapamil The serum concentration of Digoxin can be increased when it is combined with Verapamil.
Atenolol	Atenolol Atenolol may increase the arrhythmogenic activities of Digoxin.
Pindolol	Pindolol Pindolol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cisplatin Injection	Cisplatin Injection Cisplatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diflunisal	Diflunisal Diflunisal may decrease the excretion rate of Digoxin which could result in a higher serum level.
Piroxicam	Piroxicam Piroxicam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bumetanide	Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.
Etoposide	Etoposide The serum concentration of Digoxin can be increased when it is combined with Etoposide.
Glyburide	Glyburide Glyburide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Glipizide	Glipizide Glipizide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Indapamide	Indapamide Indapamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amoxicillin	Amoxicillin Amoxicillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxacillin Injection	Oxacillin Injection Oxacillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pentoxifylline	Pentoxifylline Pentoxifylline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pentamidine Injection	Pentamidine Injection Pentamidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ceftriaxone Injection	Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Labetalol	Labetalol Labetalol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Auranofin	Auranofin Auranofin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection Leuprolide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Gemfibrozil	Gemfibrozil Gemfibrozil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pimozide	Pimozide The risk or severity of QTc prolongation can be increased when Digoxin is combined with Pimozide.
Enalapril	Enalapril The excretion of Enalapril can be decreased when combined with Digoxin.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amiodarone	Amiodarone The serum concentration of Digoxin can be increased when it is combined with Amiodarone.
Aztreonam Injection	Aztreonam Injection Aztreonam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Buspirone	Buspirone Digoxin may decrease the excretion rate of Buspirone which could result in a higher serum level.
Ciprofloxacin	Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mesalamine	Mesalamine Mesalazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diclofenac	Diclofenac The serum concentration of Digoxin can be increased when it is combined with Diclofenac.
Fluoxetine	Fluoxetine The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Digoxin.
Nimodipine	Nimodipine Nimodipine may increase the arrhythmogenic activities of Digoxin.
Clozapine	Clozapine Clozapine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Estazolam	Estazolam Estazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Idarubicin	Idarubicin Digoxin may decrease the cardiotoxic activities of Idarubicin.
Ofloxacin	Ofloxacin Ofloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Didanosine	Didanosine Didanosine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fludarabine Injection	Fludarabine Injection Digoxin may decrease the cardiotoxic activities of Fludarabine.
Pentostatin Injection	Pentostatin Injection Pentostatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clarithromycin	Clarithromycin The serum concentration of Digoxin can be increased when it is combined with Clarithromycin.
Benazepril	Benazepril The risk or severity of hyperkalemia can be increased when Digoxin is combined with Benazepril.
Etodolac	Etodolac Etodolac may decrease the excretion rate of Digoxin which could result in a higher serum level.
Felodipine	Felodipine Felodipine may increase the arrhythmogenic activities of Digoxin.
Fosinopril	Fosinopril Fosinopril may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nabumetone	Nabumetone Nabumetone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pravastatin	Pravastatin Pravastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Quinapril	Quinapril The risk or severity of hyperkalemia can be increased when Digoxin is combined with Quinapril.
Ramipril	Ramipril The risk or severity of hyperkalemia can be increased when Ramipril is combined with Digoxin.
Simvastatin	Simvastatin The serum concentration of Digoxin can be increased when it is combined with Simvastatin.
Amlodipine	Amlodipine Amlodipine may increase the arrhythmogenic activities of Digoxin.
Teniposide Injection	Teniposide Injection Digoxin may decrease the cardiotoxic activities of Teniposide.
Itraconazole	Itraconazole The serum concentration of Digoxin can be increased when it is combined with Itraconazole.
Lisinopril	Lisinopril Lisinopril may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxaprozin	Oxaprozin Oxaprozin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sotalol	Sotalol Sotalol may increase the arrhythmogenic activities of Digoxin.
Bisoprolol	Bisoprolol The therapeutic efficacy of Digoxin can be increased when used in combination with Bisoprolol.
Isradipine	Isradipine Isradipine may increase the arrhythmogenic activities of Digoxin.
Omeprazole	Omeprazole The serum concentration of Digoxin can be increased when it is combined with Omeprazole.
Cisapride	Cisapride The risk or severity of QTc prolongation can be increased when Digoxin is combined with Cisapride.
Fluvastatin	Fluvastatin The excretion of Fluvastatin can be decreased when combined with Digoxin.
Venlafaxine	Venlafaxine Venlafaxine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fluvoxamine	Fluvoxamine Fluvoxamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nefazodone	Nefazodone The serum concentration of Digoxin can be increased when it is combined with Nefazodone.
Lamotrigine	Lamotrigine Lamotrigine may increase the arrhythmogenic activities of Digoxin.
Losartan	Losartan Losartan may increase the arrhythmogenic activities of Digoxin.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tramadol	Tramadol The risk or severity of adverse effects can be increased when Tramadol is combined with Digoxin.
Vinorelbine Injection	Vinorelbine Injection Digoxin may decrease the cardiotoxic activities of Vinorelbine.
Carboplatin Injection	Carboplatin Injection Carboplatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Moexipril	Moexipril The risk or severity of QTc prolongation can be increased when Digoxin is combined with Moexipril.
Lansoprazole	Lansoprazole The serum concentration of Digoxin can be increased when it is combined with Lansoprazole.
Ifosfamide Injection	Ifosfamide Injection Ifosfamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nicardipine	Nicardipine Nicardipine may increase the arrhythmogenic activities of Digoxin.
Bupropion	Bupropion Bupropion may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ticlopidine	Ticlopidine Ticlopidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Saquinavir	Saquinavir The serum concentration of Digoxin can be increased when it is combined with Saquinavir.
Metformin	Metformin The serum concentration of Digoxin can be increased when it is combined with Metformin.
Dalteparin Injection	Dalteparin Injection The risk or severity of hyperkalemia can be increased when Digoxin is combined with Dalteparin.
Nisoldipine	Nisoldipine Nisoldipine may increase the arrhythmogenic activities of Digoxin.
Lamivudine	Lamivudine Lamivudine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Acarbose	Acarbose The serum concentration of Digoxin can be decreased when it is combined with Acarbose.
Glimepiride	Glimepiride Glimepiride may increase the arrhythmogenic activities of Digoxin.
Anastrozole	Anastrozole Digoxin may decrease the cardiotoxic activities of Anastrozole.
Gemcitabine Injection	Gemcitabine Injection Gemcitabine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Indinavir	Indinavir Indinavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ritonavir	Ritonavir The bioavailability of Digoxin can be increased when combined with Ritonavir.
Docetaxel Injection	Docetaxel Injection Digoxin may decrease the cardiotoxic activities of Docetaxel.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Meropenem may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clomipramine	Clomipramine Digoxin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Fosfomycin	Fosfomycin Fosfomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mirtazapine	Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Digoxin.
Trandolapril	Trandolapril The risk or severity of hyperkalemia can be increased when Digoxin is combined with Trandolapril.
Topiramate	Topiramate Topiramate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Valsartan	Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Digoxin.
Pramipexole	Pramipexole Pramipexole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Donepezil	Donepezil Digoxin may increase the bradycardic activities of Donepezil.
Nelfinavir	Nelfinavir Nelfinavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fexofenadine	Fexofenadine The serum concentration of Digoxin can be increased when it is combined with Fexofenadine.
Azithromycin	Azithromycin The serum concentration of Digoxin can be increased when it is combined with Azithromycin.
Loratadine	Loratadine Loratadine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Carvedilol	Carvedilol The serum concentration of Digoxin can be increased when it is combined with Carvedilol.
Nilutamide	Nilutamide Nilutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Flutamide	Flutamide Flutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Propafenone	Propafenone The serum concentration of Digoxin can be increased when it is combined with Propafenone.
Raloxifene	Raloxifene The excretion of Raloxifene can be decreased when combined with Digoxin.
Irbesartan	Irbesartan The risk or severity of hyperkalemia can be increased when Digoxin is combined with Irbesartan.
Tamsulosin	Tamsulosin Tamsulosin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Quetiapine	Quetiapine Digoxin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cetirizine	Cetirizine Cetirizine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolcapone	Tolcapone Tolcapone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Citalopram	Citalopram The risk or severity of QTc prolongation can be increased when Digoxin is combined with Citalopram.
Capecitabine	Capecitabine Capecitabine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Efavirenz	Efavirenz Efavirenz may decrease the excretion rate of Digoxin which could result in a higher serum level.
Abacavir	Abacavir Abacavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sildenafil	Sildenafil Sildenafil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Trastuzumab Injection	Trastuzumab Injection Digoxin may decrease the cardiotoxic activities of Trastuzumab.
Celecoxib	Celecoxib Celecoxib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rosiglitazone	Rosiglitazone Rosiglitazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolterodine	Tolterodine Tolterodine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Thalidomide	Thalidomide Digoxin may decrease the cardiotoxic activities of Thalidomide.
Oseltamivir	Oseltamivir Oseltamivir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Aluminum Hydroxide	Aluminum Hydroxide The serum concentration of Digoxin can be decreased when it is combined with Aluminum hydroxide.
Colesevelam	Colesevelam Colesevelam can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide	Balsalazide Balsalazide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nateglinide	Nateglinide Nateglinide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Galantamine	Galantamine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Galantamine.
Rabeprazole	Rabeprazole The serum concentration of Digoxin can be increased when it is combined with Rabeprazole.

Digoxin

On this page